Cellino Promotes Engineering Leader Ed Tekeian to COO
Event summary
- Ed Tekeian, previously SVP of Engineering at Cellino, promoted to Chief Operating Officer on March 17, 2026.
- Tekeian joined Cellino in 2024, leading engineering and platform development for automated biomanufacturing.
- Cellino's platform focuses on scalable manufacturing of induced pluripotent stem cells (iPSCs) for regenerative therapies.
- Tekeian has 30+ years of experience in hardware/software engineering, with prior roles at Formlabs, Kuvée, and 3M Health Care.
The big picture
Cellino’s promotion of Tekeian to COO underscores its push toward scalable, automated biomanufacturing for regenerative therapies. The move aligns with broader industry trends toward personalized medicine and industrial-scale stem cell production. With FDA designation already secured, the focus now shifts to operational execution and market penetration.
What we're watching
- Operational Scaling
- How Tekeian’s leadership will accelerate Cellino’s platform deployment and manufacturing reliability.
- Regulatory Compliance
- Whether Cellino can sustain FDA Advanced Manufacturing Technology designation while scaling operations.
- Market Expansion
- The pace at which Cellino can make personalized regenerative medicine broadly accessible.
Related topics